C12N 5/0661
Smooth muscle cells
Official title: {Smooth muscle cells}
C12N5/0661 (Smooth muscle cells) appears on 62 US grants and 122 published applications in this corpus.
Search patents in C12N- Granted patents
- 62
- Published applications
- 122
- Assignees
- 79
- Inventors
- 244
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 3 |
| 2003 | 2 | 2 |
| 2004 | 2 | 2 |
| 2005 | 0 | 1 |
| 2006 | 2 | 4 |
| 2007 | 1 | 1 |
| 2008 | 1 | 2 |
| 2009 | 2 | 2 |
| 2010 | 1 | 3 |
| 2011 | 1 | 4 |
| 2012 | 1 | 3 |
| 2013 | 2 | 4 |
| 2014 | 3 | 8 |
| 2015 | 2 | 4 |
| 2016 | 2 | 7 |
| 2017 | 3 | 5 |
| 2018 | 3 | 8 |
| 2019 | 3 | 7 |
| 2020 | 4 | 12 |
| 2021 | 5 | 8 |
| 2022 | 3 | 6 |
| 2023 | 2 | 5 |
| 2024 | 5 | 6 |
| 2025 | 6 | 6 |
| 2026 | 2 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tissue engineered vascular grafts29 Sep 2026US 12,746,309 B2Medtronic, Inc.
- Methods of preconditioning vascular cells for transduction, methods of transduction and methods of preserving transduced cells4 Aug 2026US 12,698,477 B2Vessi Therapeutics Ltd
- Lineage reprogramming to induced cardiac progenitor cells (iCPC) by defined factors7 Oct 2025US 12,435,313 B2Wisconsin Alumni Research Foundation
- Human pluripotent stem cell-based screening for smooth muscle cell differentiation and disease9 Sep 2025US 12,410,404 B2Wisconsin Alumni Research Foundation (WARF)
- Methods for obtaining induced smooth muscle cells27 May 2025US 12,312,600 B2Innovacell AG
- Hybrid hydrogels for culturing endometrial and stromal organoid cells20 Aug 2026US 2026/0242723 A1Massachusetts Institute of Technology
- Artificial tissue tube and method for producing same23 Jul 2026US 2026/0209707 A1Keio University
- Reprogrammed smooth muscle cells and methods related thereto16 Jul 2026US 2026/0201336 A1Emory University
- Lineage Reprogramming to Induced Cardiac Progenitor Cells (iCPC) By Defined Factors9 Jul 2026US 2026/0193611 A1Wisconsin Alumni Research Foundation
- Methods and systems for converting precursor cells into intestinal tissues through directed differentiation30 Apr 2026US 2026/0117190 A1Children's Hospital Medical Center
Most cited
By later US patents
- Transplants for myocardial scars141US 6,099,832 AGenzyme Corporation · 2000
- Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-.beta. super family growth factors78US 6,001,654 ACalifornia Institute of Technology · 1999
- Transplants for myocardial scars44US 6,682,730 B2Genzyme Corporation · 2004
- Smooth muscle tissue formation in vivo using cultured smooth muscle cells combined with an extracellular matrix22US 5,656,478 AThe Regents of the University of California · 1997
- Neuroepithelial stem cells and glial-restricted intermediate precursors21US 6,361,996 B1University of Utah Research Foundation · 2002